Discover who we are, our purpose and the aspirations which have always inspired AXA.

Discover

All around the world, women are disproportionately impacted by risks.

Being a woman shouldn’t be a risk

In this Integrated Report, we share with you our vision, our ambitions and our initiatives to continue to be a world leader in insurance, but also a committed player in our society.

Unlock The Future - 2023 Integrated Report

You are valued. Your voice is important. We care about you and your wellbeing.

Thrive within a Diverse Community

About Us

History

Purpose, Vision and Values

Missions

Property & Casualty

Life & Savings and Health

Asset Management

Strategic Plan: Unlock the Future 2026

Our diverse community

Profile and Key Figures

Financial Data

Our People

Key Figures

Corporate Governance

Governance Overview

Board of Directors

Board Committees

Executive Management

Towards an ever more Responsible & Sustainable Model. Our commitments focus on three key areas - the planet, the people, our products – with multiple initiatives and day-to-day actions to achieve our goals.

See how we manage our impact on the environment by reducing resource use and promoting climate change awareness.

Climate Change & Biodiversity

AXA strives to play a positive role in society, by building a culture that promotes employee volunteering and helping to build better understanding of the risks faced by individuals and society at large.

Philanthropy & Volunteering

The AXA Research Fund's mission is to support independent academic research in key areas related to risk.

Accelerating science to protect what matters

Commitments

Vision & Strategy

AXA for Progress Index

Governance

Partnerships & Memberships

Insurance

Investments

ESG Performance

Our strategy

Climate change

Biodiversity

Environmental footprint management

Inclusive Protection

AXA Emerging Customers

Women in Insurance

AXA Climate, Engaged Climate Insurer

Philanthropy

Research

Volunteering

COVID highlights

Responsible Corporation

Cyber Security and Data privacy

Human rights & Vigilance plan

Compliance & ethics

Public affairs

Tax transparency

Suppliers

Human Resources

Subscribe to email alerts

Our financial results, business activities, solutions and recent sustainable initiatives: news, analysis and viewpoints.

Future Risks Report 2024

News

2024 New AXA Compliance & Ethics Code

AXA has made a good start to its new strategic plan ‘Unlock the Future’.

Half Year 2024 Earnings

AXA publishes its strategic plan and its key financial targets for 2024-2026.

Unlock the Future

Home Press

Press Releases

Leader's Voice

Financial Results

Publications

Events and Conferences

Press

Investor Relations

Individual Shareholders

The AXA Share

AXA Share Performance

Share buy-back

Listings and Market Indices

Capital Ownership

Analysts Coverage

Ratings

Being a Shareholder

AXA Shareholders' Circle

Advisory Committee for Individual Shareholders

Shareholders' Meetings

Pure registered shares with AXA

Earnings and Reports

Earnings Presentations

Annual and Interim Reports

Analysts and Investors

Legal Information and Financing

Financing

Organization Chart

Sustainability Bond Framework and Reports

Listed Notes (EMTN)

Listed notes (other)

Equity or Equity linked

Regulated Information

Home Investor

Investors

Learn more on our compensation policy and see how benefits are an important part of our overall value proposition for employees.

Compensation and benefits

AXA enhances the role and place of employees over the age of 50 in the company.

AXA is committed to valuing and supporting its employees over the age of 50

Let's realize your potential

Apply Now

Careers

Mr. Davis joined PATH as its president and CEO in June 2012. Previously he served as a leader and strategist for a range of organizations, including as CEO of internet pioneer and global digital media firm Corbis, director of social innovation for McKinsey & Company, and interim CEO of the Infectious Disease Research Institute. He is a member of the Council on Foreign Relations and holds a faculty appointment as a lecturer at the Stanford Graduate School of Business. He currently serves on the boards of InterAction and Global Partnerships and is an advisor to groups including the World Economic Forum's Global Agenda Council on Social Innovation, the Clinton Global Initiative's Global Health Advisory Board, and the Council on Foreign Relation's Task Force on Non-Infectious Diseases.

The Panel is composed of 7 permanent external members, each with a mandate of 3 years, renewable twice.

Stakeholder advisory panelists

Mr. Eberstadt holds the Henry Wendt Chair in political Economy at the American Enterprise Institute (AEI), serves as Senior Adviser to the National Bureau of Asian Research (NBR), and is currently also Visiting Research Fellow at the Asian Institute for Public Policy in Seoul. He joined the American Enterprise Institute as a visiting fellow in 1985. He assumed the Henry Wendt Chair in Political Economy and became a resident scholar in 1999. He is also inter alia a founding member of the U.S. Committee for Human Rights in North Korea, and a member of the Advisory Council for the Global Coalition on Aging (GCOA). In 2012 Mr. Eberstadt won the prestigious Bradley Prize in the United States. Mr Eberstadt earned his AB, MPA and Ph.D. at Harvard and his M.Sc. at the London School of Economics.

Appointed on April 23, 2024 – Term expires at the 2027 Shareholders’ Meeting
First appointment on April 27, 2016
Member to the AXA Audit Committee
Number of AXA shares held on December 31, 2023: 7,250

Dr. Angelien Kemna graduated with a Master of Arts in Econometrics and a Ph.D. in Finance from Erasmus University Rotterdam (The Netherlands). She was a visiting scholar at the Sloan School, MIT (United States). Dr. Angelien Kemna began her career as Associate Professor in Finance at the Erasmus University from 1988 to 1991. In 1992, she joined Robeco NV and held various positions, notably Investments and Account Management Director from 1998 to 2001. During this period, she was also part-time Professor of Financial Markets at the University of Maastricht (The Netherlands) (1993–1999). From 2001 to July 2007, she worked for ING Investment Management BV (The Netherlands), where she initially held the position of Global Chief Investment Officer and subsequently Chief Executive Officer for the European Region. In the period 2007-2011, Dr. Angelien Kemna was part-time Professor of corporate governance at the Erasmus University and had also various non-executive and advisory positions, most notably Vice-Chairwoman of the Supervisory Board of the Dutch regulatory institution (AFM). In 2009, Dr.  Angelien Kemna joined APG group NV as member of the Executive Board with the responsibility of Chief Investment Officer. From September 2014 to November 2017, Dr. Angelien Kemna was Chief Finance & Risk Officer of APG group (The Netherlands).

Director: AXA, AXA Investment Managers (Senior Independent Director)

Director or member of the Supervisory Board: NIBC (The Netherlands), Naspers (South Africa), Prosus (The Netherlands)

Director: Friesland Campina N.V. (The Netherlands)

Composition of the Board of Directors on April 23, 2024

Meet the members of our Board of Directors and find out more about their directorship, experience and expertise.

Members of the Board of Directors

Maria A. Ressa is a Filipino journalist, and the CEO and Executive Editor of Rappler, a social news network.

Ms. Ressa has been a journalist in Asia for nearly 30 years, most of them as CNN’s bureau chief in Manila (1987-1995) then Jakarta (1995-2005). She was CNN’s lead investigative reporter focusing on terrorism in South-East Asia and wrote Seeds of Terror: An Eyewitness Account of al-Qaeda’s Newest Center of Operations in South-East (Free Press, 2003). 

In 2005, she took the helm of ABS-CBN News and Current affairs, for six years determining strategic direction and managing more than 1,000 journalists for the largest multi-platform news operation in the Philippines. 

She has taught courses in Politics and the Press in Southeast Asia for her alma mater, Princeton University, and in broadcast journalism for the University of the Philippines. She worked on her second book, From Bin Laden to Facebook as author-in-residence and Senior Fellow at the International Centre for Political Violence & Terrorism Research in Singapore.  She is also the South-East Asia Visiting Scholar at CORE Lab at the Naval Postgraduate School in Monterey, California.

Sangu Delle is a Ghanaian investor and entrepreneur. Mr. Delle was selected by Forbes in the ‘30-under-30 entrepreneurs’ list in Africa in 2014. Mr. Delle is Managing Director of Africa Health Holdings, a company based in West Africa, which aspires to "build Africa's healthcare future". In 2008, he founded Golden Palm Investments, an investment holding and advisory company focused on high growth and impact industry sectors across Africa. He is currently Chairman of the Board of Stawi Foods & Fruits, a Kenyan award-winning food processing business primarily involved in the milling of nutritious porridge flours. He is also Director of mPharma, a startup in data and cost management connecting African consumers to accessible and affordable high-quality medications. He previously worked as an analyst at Goldman Sachs, Morgan Stanley and Valiant Capital Partners. He is a Trustee of the Peddie School.

Mr. Delle studied at Harvard University – he graduated with a B.A. (Highest Honors) from Harvard College, an MBA from Harvard Business School and a Doctor of Law from Harvard Law School – where he is now an Advisory Board member as well as co-Chair of the Leadership Council at the Harvard Centre for African Studies and an Elected Director of Harvard's Alumni Association.

Mr. Delle is also invested in non-profit activities: he is the co-founder and President of cleanacwa, a non-profit working to provide access to clean water in Ghana’s underdeveloped regions. He is an Advisory Board Member of the African Technology Foundation, a non-profit which supports African technology start-ups, and a Founding Member of the Rhodes Scholarship for West Africa at Oxford University. Mr. Delle is also a Soros Fellow and a TEDGlobal Fellow.

Sangu Delle, Founder, Chairman and CEO of Golden Palm Investments

Ameera Shah, Managing Director of Metropolis Healthcare

Prior to his work at The Nature Conservancy, Mark Tercek was a managing director and partner at Goldman Sachs for 24 years. He worked in Corporate Finance and Equity Capital Markets before developing the firm’s environmental strategy and leading its Environmental Markets Group in 2005.

In 2012, Mark Tercek was appointed by New York Governor Andrew Cuomo to serve on the New York State 2100 Commission (advise the governor and the state on how to make the state’s infrastructure more resilient to future storms). In 2016, Mark was appointed by President Barack Obama to the president's Advisory Committee for Trade Policy and Negotiations.

He is co-author of the book Nature’s Fortune: How Business and Society Thrive by Investing in Nature.

Mark Tercek serves on various boards: Resources for the Future, the Nicholas Institute for Environmental Policy Solutions, the China Council for International Cooperation on Environment and Development (CCICED), the Rockefeller Foundation Economic Council on Planetary Health, Harvard Business School's Social Enterprise Initiative. He serves on the Williams College Board of Trustees and was on the finance faculty of New York University’s Stern School of Business until 2008.

Alma mater: B.A. from Williams College in 1979; M.B.A. from Harvard in 1984.

Mark Tercek is President and CEO of The Nature Conservancy.

Mark Tercek, President and CEO of The Nature Conservancy.

AXA

About AXA

Stakeholder advisory panelists

Steve Davis

Nicholas Eberstadt

Dr. Angelien Kemna

Maria Ressa

Sangu Delle

Ameera Shah

Mark Tercek